scispace - formally typeset
D

Donald C. Monkhouse

Researcher at Princeton University

Publications -  29
Citations -  1580

Donald C. Monkhouse is an academic researcher from Princeton University. The author has contributed to research in topics: Dosage form & Drug carrier. The author has an hindex of 15, co-authored 29 publications receiving 1508 citations. Previous affiliations of Donald C. Monkhouse include University of Akron & Massachusetts Institute of Technology.

Papers
More filters
Journal ArticleDOI

A three-dimensional osteochondral composite scaffold for articular cartilage repair.

TL;DR: A unique, heterogeneous, osteochondral scaffold is developed using the TheriForm three-dimensional printing process, suggesting that these scaffolds have desirable mechanical properties for in vivo applications, including full joint replacement.
Patent

A complex three-dimensional composite scaffold resistant to delamination

TL;DR: In this paper, the authors describe composite implantable devices having a gradient of one or more of the following: materials, macro-architecture, microarchitectures or mechanical properties, which can be used to select or promote attachment of specific cell types on and in the devices prior to and/or after implantation.
Patent

Method and apparatus for engineered regenerative biostructures such as hydroxyapatite substrates for bone healing applications

TL;DR: An engineered regenerative biostructure (erb) for implantation into a human body as a bone substitute, which includes an internal microstructure, mesostructure and/or macrostructure to provide improved bone in-growth, and methods for making the erb.
Patent

Rapid prototyping and manufacturing process

TL;DR: In this paper, a computer-guided system is used to vary the composition and structure in order to optimize the product and the manufacturing process, which can be used to recommend different compositions and designs of the prototypes, devices, dosage forms, tissue scaffolds or other bioaffecting agents.
Journal ArticleDOI

Development of near zero-order release dosage forms using three-dimensional printing (3-DP) technology.

TL;DR: Qualitative rank order linear correlations between in vivo absorption profiles and in vitro dissolution parameters (with slope and intercept close to unity and origin, respectively) were obtained for all three formulations, indicating good support for a Level A in vivo/in vitro correlation.